MediPharm Labs (MediPharm Labs) Change In Receivables : $4.35 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is MediPharm Labs Change In Receivables?

MediPharm Labs's change in receivables for the quarter that ended in Mar. 2024 was $-0.46 Mil. It means MediPharm Labs's Accounts Receivable increased by $0.46 Mil from Dec. 2023 to Mar. 2024 .

MediPharm Labs's change in receivables for the fiscal year that ended in Dec. 2023 was $4.79 Mil. It means MediPharm Labs's Accounts Receivable declined by $4.79 Mil from Dec. 2022 to Dec. 2023 .

MediPharm Labs's Accounts Receivable for the quarter that ended in Mar. 2024 was $4.59 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. MediPharm Labs's Days Sales Outstanding for the three months ended in Mar. 2024 was 58.06.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. MediPharm Labs's liquidation value for the three months ended in Mar. 2024 was $11.17 Mil.

MediPharm Labs Change In Receivables Historical Data

The historical data trend for MediPharm Labs's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs Change In Receivables Chart

MediPharm Labs Annual Data

Trend

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-16.00

-5.14

7.96

2.66

4.79

MediPharm Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-0.02	0.68	-0.17	4.30	-0.46

MediPharm Labs Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.35 Mil.

MediPharm Labs (OTCPK:MEDIF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

MediPharm Labs's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	4.593	/	7.219	*	91
=	58.06

2. In Ben Graham's calculation of liquidation value, MediPharm Labs's accounts receivable are only considered to be worth 75% of book value:

MediPharm Labs's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	12.504	-	8.415	+	0.75 * 4.593	+	0.5 * 7.279
=	11.17

MediPharm Labs Change In Receivables Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

MediPharm Labs (MediPharm Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (OTCPK:MEDIF) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

MLZ:Germany LABS:Canada

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.